72 Investment Holdings, LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), 72 Investment Holdings, LLC reported 6 stock positions worth $35.6 million. Its top holding was Lenz Therapeutics (LENZ) at 73.5% of the portfolio, followed by Korro Bio (KRRO, 13.5%) and Praxis Precision Medicines I (PRAX, 7.0%). Compared with Q4 2024, it sold out of 1. The biggest sale was an exit from Omega Therapeutics (OMGAQ).
- Most Recent 13F
- Q2 2026
- Location
- STAMFORD, CT
- CIK
- 0001832749
- Portfolio Value
- $35.6M (Q1 2025)
- SEC Filing
- 0000902664-25-002401 ↗ filed May 15, 2025
Holdings Value
Holdings 6 stocks · $35.6M
| LENZ Lenz Therapeutics Inc. | 73.53% | 1,017,751 | $26.2M | No change |
| KRRO Korro Bio Inc. | 13.54% | 276,831 | $4.8M | No change |
| PRAX Praxis Precision Medicines I | 7.02% | 65,933 | $2.5M | No change |
| ANRO Alto Neuroscience Inc. | 4.05% | 667,778 | $1.4M | No change |
| CRBU Caribou Biosciences Inc. | 1.22% | 474,067 | $433K | No change |
| TSBX Turnstone Biologics Corp. | 0.63% | 549,980 | $225K | No change |
Portfolio Sells Q4 2024 → Q1 2025
| OMGAQ Omega Therapeutics Inc. | Sold out | 0.00% | −0.54 |
Portfolio Buys Q4 2024 → Q1 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $50.0M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q1 2026 | 5 | $49.6M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q4 2025 | 5 | $50.6M | PRAX, LENZ, ANRO, KRRO, CRBU |
| Q3 2025 | 5 | $67.9M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q2 2025 | 6 | $38.3M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q1 2025 | 6 | $35.6M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q4 2024 | 7 | $49.1M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q3 2024 | 7 | $46.5M | LENZ, KRRO, ANRO, PRAX, CRBU |
| Q2 2024 | 7 | $39.8M | LENZ, KRRO, ANRO, PRAX, TSBX |
| Q1 2024 | 7 | $67.1M | KRRO, LENZ, ANRO, PRAX, CRBU |